Barely Significant
← all excerpts

Opicapone for the Treatment of Nocturnal Hypokinesia in Patients With Parkinson's Disease: An Open-Label Pilot Clinical Trial.

J Mov Disord · 2026 · PMC12885641 · PMID 41261362

1
hedged sentence
closest p
boldest claim

The sentences

These general sleep questionnaires do not include NH-specific questions except Item 9 of the PDSS-2—“Did you feel uncomfortable at night because you were unable to turn around in bed or move due to immobility?” [ 8 ] This may partially explain why changes in these secondary outcomes did not reach statistical significance in the present study.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.